tetano
Editor, Senior Moderator
Nucleic Acids Res
. 2020 Nov 10;gkaa1053.
doi: 10.1093/nar/gkaa1053. Online ahead of print.
Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements
Ilaria Manfredonia[SUP] 1 [/SUP], Chandran Nithin[SUP] 2 [/SUP], Almudena Ponce-Salvatierra[SUP] 2 [/SUP], Pritha Ghosh[SUP] 2 [/SUP], Tomasz K Wirecki[SUP] 2 [/SUP], Tycho Marinus[SUP] 1 [/SUP], Natacha S Ogando[SUP] 3 [/SUP], Eric J Snijder[SUP] 3 [/SUP], Martijn J van Hemert[SUP] 3 [/SUP], Janusz M Bujnicki[SUP] 2 [/SUP], Danny Incarnato[SUP] 1 [/SUP]
Affiliations
Abstract
SARS-CoV-2 is a betacoronavirus with a linear single-stranded, positive-sense RNA genome, whose outbreak caused the ongoing COVID-19 pandemic. The ability of coronaviruses to rapidly evolve, adapt, and cross species barriers makes the development of effective and durable therapeutic strategies a challenging and urgent need. As for other RNA viruses, genomic RNA structures are expected to play crucial roles in several steps of the coronavirus replication cycle. Despite this, only a handful of functionally-conserved coronavirus structural RNA elements have been identified to date. Here, we performed RNA structure probing to obtain single-base resolution secondary structure maps of the full SARS-CoV-2 coronavirus genome both in vitro and in living infected cells. Probing data recapitulate the previously described coronavirus RNA elements (5' UTR and s2m), and reveal new structures. Of these, ∼10.2% show significant covariation among SARS-CoV-2 and other coronaviruses, hinting at their functionally-conserved role. Secondary structure-restrained 3D modeling of these segments further allowed for the identification of putative druggable pockets. In addition, we identify a set of single-stranded segments in vivo, showing high sequence conservation, suitable for the development of antisense oligonucleotide therapeutics. Collectively, our work lays the foundation for the development of innovative RNA-targeted therapeutic strategies to fight SARS-related infections.
. 2020 Nov 10;gkaa1053.
doi: 10.1093/nar/gkaa1053. Online ahead of print.
Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements
Ilaria Manfredonia[SUP] 1 [/SUP], Chandran Nithin[SUP] 2 [/SUP], Almudena Ponce-Salvatierra[SUP] 2 [/SUP], Pritha Ghosh[SUP] 2 [/SUP], Tomasz K Wirecki[SUP] 2 [/SUP], Tycho Marinus[SUP] 1 [/SUP], Natacha S Ogando[SUP] 3 [/SUP], Eric J Snijder[SUP] 3 [/SUP], Martijn J van Hemert[SUP] 3 [/SUP], Janusz M Bujnicki[SUP] 2 [/SUP], Danny Incarnato[SUP] 1 [/SUP]
Affiliations
- PMID: 33166999
- DOI: 10.1093/nar/gkaa1053
Abstract
SARS-CoV-2 is a betacoronavirus with a linear single-stranded, positive-sense RNA genome, whose outbreak caused the ongoing COVID-19 pandemic. The ability of coronaviruses to rapidly evolve, adapt, and cross species barriers makes the development of effective and durable therapeutic strategies a challenging and urgent need. As for other RNA viruses, genomic RNA structures are expected to play crucial roles in several steps of the coronavirus replication cycle. Despite this, only a handful of functionally-conserved coronavirus structural RNA elements have been identified to date. Here, we performed RNA structure probing to obtain single-base resolution secondary structure maps of the full SARS-CoV-2 coronavirus genome both in vitro and in living infected cells. Probing data recapitulate the previously described coronavirus RNA elements (5' UTR and s2m), and reveal new structures. Of these, ∼10.2% show significant covariation among SARS-CoV-2 and other coronaviruses, hinting at their functionally-conserved role. Secondary structure-restrained 3D modeling of these segments further allowed for the identification of putative druggable pockets. In addition, we identify a set of single-stranded segments in vivo, showing high sequence conservation, suitable for the development of antisense oligonucleotide therapeutics. Collectively, our work lays the foundation for the development of innovative RNA-targeted therapeutic strategies to fight SARS-related infections.